loader

cynata therapeutics

LATEST ARTICLES
pharmaceutical investing

Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD

Cynata Therapeutics Completes Patent Application to Cover Cymerus Stem Cell Technology

Cynata Therapeutics Receives Orphan Drug Designation from FDA

FDA Grants Orphan Drug Designation to Cynata’s Lead Cymerus MSC Product, CYP-001

Excellent Cohort A Data From Final Primary Evaluation Period in Cynata GvHD Phase 1 Clinical Trial

Treatment Commences in Second Patient Cohort in Cynata’s World First Clinical Trial

longevity investing

Cynata Executes MoU for Commercial Evaluation with Celularity

What Is Regenerative Medicine?

Genetics Outlook 2017: The Revolution Nears

Top Trends for Genetics Stocks in 2017

Is the Stem Cell Market Heating Up? Acquisition Activity Suggests Yes.

How 3 Top Stem Cell Research Companies Are Changing Biotech Investing

How 3 Top Stem Cell Research Companies Are Changing Biotech Investing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES